Search Results - Wasan, Harpreet S..
-
1
The potential benefit of encorafenib plus cetuximab with chemotherapy compared with standard of care in people with BRAF V600E-mutant metastatic colorectal cancer in the BREAKWATER...
Article | by Yoshino, Takayuki; Van Cutsem, Eric; Eng, Cathy; Kim, Tae Won; Wasan, Harpreet; Kopetz, Scott; Tabernero, Josep | Published 2025 |Other Authors: “…Wasan, Harpreet…”
-
2
SCOT
Article | by Robles-Zurita, José; Boyd, Kathleen A.|||0000-0002-9764-0113; Briggs, Andrew H.; Iveson, Timothy; Kerr, Rachel S.; Saunders, Mark P.; Cassidy, Jim; Hollander, Niels Henrik; Tabernero, Josep|||0000-0002-2495-8139; Segelov, Eva; Glimelius, B.; Harkin, Andrea; Allan, Karen; McQueen, John; Pearson, Sarah; Waterston, Ashita; Medley, Louise; Wilson, Charles; Ellis, Richard; Essapen, Sharadah; Dhadda, Amandeep S.; Hughes, Rob; Falk, Stephen; Raouf, Sherif; Rees, Charlotte; Olesen, Rene K.; Propper, David; Bridgewater, John; Azzabi, Ashraf; Farrugia, David; Webb, Andrew; Cunningham, David; Hickish, Tamas; Weaver, Andrew; Gollins, Simon; Wasan, Harpreet S..; Paul, James | Published 2018 |Other Authors: “…Wasan, Harpreet S..…”
-
3
The potential benefit of encorafenib plus cetuximab with chemotherapy compared with standard of care in people with BRAF V600E-mutant metastatic colorectal cancer in the BREAKWATER...
Article | by Yoshino, Takayuki; Van Cutsem, Eric; Eng, Cathy; Kim, Tae Won; Wasan, Harpreet; Kopetz, Scott; Tabernero, Josep | Published 2025 |Other Authors: “…Wasan, Harpreet…”
-
4
Encorafenib, Binimetinib, and Cetuximab in BRAF V600E-Mutated Colorectal Cancer
Article | by Kopetz, Scott; Grothey, Axel; Yaeger, Rona; Van Cutsem, Eric; Desai, Jayesh; Yishino, Takayuki; Wasan, Harpreet; Ciardiello, Fortunato; Loupakis, Fotio; Tabernero, Josep | Published 2019 |Other Authors: “…Wasan, Harpreet…”
-
5
Binimetinib, Encorafenib, and Cetuximab Triplet Therapy for Patients With BRAF V600E-Mutant Metastatic Colorectal Cancer
Article | by Van Cutsem, Eric|||0000-0002-6372-1230; Huijberts, Sanne; Grothey, Axel; Yaeger, Rona|||0000-0002-7233-5454; Cuyle, Pieter-Jan; Elez, Elena|||0000-0002-4653-6324; Fakih, Marwan|||0000-0002-6554-5488; Montagut, Clara; Peeters, Marc; Yoshino, Takayuki|||0000-0002-0489-4756; Wasan, Harpreet; Desai, Jayesh; Ciardiello, Fortunato; Gollerkeri, Ashwin; Christy-Bittel, Janna; Maharry, Kati; Sandor, Victor; Schellens, Jan H. M.; Kopetz, Scott; Tabernero, Josep|||0000-0002-2495-8139 | Published 2019 |Other Authors: “…Wasan, Harpreet…”
-
6
Encorafenib plus cetuximab as a new standard of care for previously treated BRAF V600E-mutant metastatic colorectal cancer: Updated survival results and subgroup analyses from the...
Article | by Tabernero, Josep; Grothey, Axel; Van Cutsem, Eric; Wasan, Harpreet; Yoshino, Takayuki; Desai, Jayesh; Ciardiello, Fortunato; Loupakis, Fotio; Hong, Yong Sang | Published 2021 |Other Authors: “…Wasan, Harpreet…”
-
7
Encorafenib, cetuximab and chemotherapy in BRAF-mutant colorectal cancer: a randomized phase 3 trial
Article | by Eng, Cathy; Kim, Tae Won; Wasan, Harpreet; Kopetz, Scott; Yoshino, Takayuki; Van Cutsem, Eric; Tabernero, Josep | Published 2025 |Other Authors: “…Wasan, Harpreet…”
-
8
Encorafenib, cetuximab and chemotherapy in BRAF-mutant colorectal cancer: a randomized phase 3 trial
Article | by Eng, Cathy; Kim, Tae Won; Wasan, Harpreet; Kopetz, Scott; Yoshino, Takayuki; Van Cutsem, Eric; Tabernero, Josep | Published 2025 |Other Authors: “…Wasan, Harpreet…”
-
9
Encorafenib Plus Cetuximab as a New Standard of Care for Previously Treated BRAF V600E–Mutant Metastatic Colorectal Cancer: Updated Survival Results and Subgroup Analyses from the...
Article | by Tabernero Caturla, Josep; Grothey, Axel; Van Cutsem, Eric; Wasan, Harpreet; Yoshino, Takayuki; Yaeger, Rona | Published 2021 |Other Authors: “…Wasan, Harpreet…”
-
10
Encorafenib Plus Cetuximab as a New Standard of Care for Previously Treated BRAF V600E–Mutant Metastatic Colorectal Cancer: Updated Survival Results and Subgroup Analyses from the...
Article | by Tabernero Caturla, Josep; Grothey, Axel; Van Cutsem, Eric; Wasan, Harpreet; Yoshino, Takayuki; Yaeger, Rona | Published 2021 |Other Authors: “…Wasan, Harpreet…”
Search Tools:
Related Subjects
DISEASES::Neoplasms::Neoplasms by Site::Digestive System Neoplasms::Gastrointestinal Neoplasms::Intestinal Neoplasms::Colorectal Neoplasms
ENFERMEDADES::neoplasias::neoplasias por localización::neoplasias del sistema digestivo::neoplasias gastrointestinales::neoplasias intestinales::neoplasias colorrectales
ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Therapeutics::Therapeutics::Drug Therapy::Antineoplastic Protocols::Therapeutics::Drug Therapy::Antineoplastic Combined Chemotherapy Protocols
Còlon - Càncer - Tractament
Other subheadings::Other subheadings::Other subheadings::/drug therapy
Otros calificadores::Otros calificadores::Otros calificadores::/farmacoterapia
Recte - Càncer - Tractament
TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::terapéutica::terapéutica::farmacoterapia::protocolos antineoplásicos::terapéutica::farmacoterapia::protocolos de quimioterapia antineoplásica combinada
Anomalies cromosòmiques
Avaluació de resultats (Assistència sanitària)
FENÓMENOS Y PROCESOS::fenómenos genéticos::variación genética::mutación
PHENOMENA AND PROCESSES::Genetic Phenomena::Genetic Variation::Mutation
Quimioteràpia combinada
ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Diagnosis::Prognosis::Treatment Outcome
ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Diagnosis::Prognosis::Treatment Outcome::Progression-Free Survival
ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Investigative Techniques::Epidemiologic Methods::Data Collection::Surveys and Questionnaires::Health Care Surveys::Patient Reported Outcome Measures
ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Therapeutics::Clinical Protocols::Antineoplastic Protocols::Antineoplastic Combined Chemotherapy Protocols
Anticossos monoclonals - Ús terapèutic
CHEMICALS AND DRUGS::Amino Acids, Peptides, and Proteins::Proteins::Blood Proteins::Immunoproteins::Immunoglobulins::Antibodies::Antibodies, Monoclonal
COMPUESTOS QUÍMICOS Y DROGAS::aminoácidos, péptidos y proteínas::proteínas::proteínas sanguíneas::inmunoproteínas::inmunoglobulinas::anticuerpos::anticuerpos monoclonales
Chemotherapy
Còlon -- Càncer
Intestí gros - Càncer
Medicaments antineoplàstics - Ús terapèutic - Eficàcia
Other subheadings::Other subheadings::/therapeutic use
Otros calificadores::Otros calificadores::/uso terapéutico
TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::diagnóstico::pronóstico::resultado del tratamiento
TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::diagnóstico::pronóstico::resultado del tratamiento::supervivencia libre de progresión
TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::terapéutica::protocolos clínicos::protocolos antineoplásicos::protocolos de quimioterapia antineoplásica combinada
TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::técnicas de investigación::métodos epidemiológicos::recopilación de datos::encuestas y cuestionarios::encuestas sobre atención a la salud::medidas de resultados percibidos por los pacientes